88 related articles for article (PubMed ID: 1899177)
1. The effect of divalent cations on the conformation and function of human plasminogen.
Stack S; Gonzalez-Gronow M; Pizzo SV
Arch Biochem Biophys; 1991 Jan; 284(1):58-62. PubMed ID: 1899177
[TBL] [Abstract][Full Text] [Related]
2. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
Petersen LC; Brender J; Suenson E
Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
[TBL] [Abstract][Full Text] [Related]
3. The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase.
Urano T; Chibber BA; Castellino FJ
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4031-4. PubMed ID: 3473492
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody to the epsilon-aminocaproic acid binding site on the kringle 4 region of human plasminogen that accelerates the activation of Glu1-plasminogen by urokinase.
Cummings HS; Castellino FJ
Arch Biochem Biophys; 1985 Feb; 236(2):612-8. PubMed ID: 2982318
[TBL] [Abstract][Full Text] [Related]
5. The activation of human [Glu1]plasminogen by human single-chain urokinase.
Urano T; de Serrano VS; Gaffney PJ; Castellino FJ
Arch Biochem Biophys; 1988 Jul; 264(1):222-30. PubMed ID: 2456035
[TBL] [Abstract][Full Text] [Related]
6. Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride.
Young TN; Edelberg JM; Stack S; Pizzo SV
Arch Biochem Biophys; 1992 Aug; 296(2):530-8. PubMed ID: 1385938
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the streptokinase-catalyzed activation of human plasminogen by human fibrinogen and its plasminolysis products.
Strickland DK; Morris JP; Castellino FJ
Biochemistry; 1982 Feb; 21(4):721-8. PubMed ID: 7200372
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
Lee PP; Wohl RC; Boreisha IG; Robbins KC
Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
[TBL] [Abstract][Full Text] [Related]
9. Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator.
Urano T; Sator de Serrano V; Gaffney PJ; Castellino FJ
Biochemistry; 1988 Aug; 27(17):6522-8. PubMed ID: 3146348
[TBL] [Abstract][Full Text] [Related]
10. Control of human plasminogen activation.
Castellino FJ; Urano T; de Serrano V; Morris JP; Chibber BA
Haemostasis; 1988; 18 Suppl 1():15-23. PubMed ID: 3127307
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the murine plasminogen/urokinase-type plasminogen-activator system.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1996 Nov; 241(3):840-8. PubMed ID: 8944773
[TBL] [Abstract][Full Text] [Related]
12. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
13. Effects of human fibrinogen and its cleavage products on activation of human plasminogen by streptokinase.
Chibber BA; Morris JP; Castellino FJ
Biochemistry; 1985 Jul; 24(14):3429-34. PubMed ID: 4041421
[TBL] [Abstract][Full Text] [Related]
14. Induction of catalytic activity of plasminogen by monoclonal antibody IV-Ic in the presence of divalent metal cations and alpha2-antiplasmin.
Sokolovskaya LI; Slominskii AY; Volkov GL
Biochemistry (Mosc); 2006 Jun; 71(6):627-33. PubMed ID: 16827654
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-catalysed plasminogen activation. Effects of ligands binding to the AH-site of plasminogen.
Christensen U
Biochim Biophys Acta; 1988 Nov; 957(2):258-65. PubMed ID: 3191143
[TBL] [Abstract][Full Text] [Related]
16. Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma.
Gaffney PJ; Urano T; de Serrano VS; Mahmoud-Alexandroni M; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1988 May; 85(10):3595-8. PubMed ID: 3130631
[TBL] [Abstract][Full Text] [Related]
17. The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen.
Stack MS; Pizzo SV
Arch Biochem Biophys; 1994 Feb; 309(1):117-22. PubMed ID: 8117101
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
Kouemo S; McMillan E; Doctor V
Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin).
Wang J; Mazar A; Quan N; Schneider A; Henkin J
Eur J Biochem; 1997 Jul; 247(1):256-61. PubMed ID: 9249034
[TBL] [Abstract][Full Text] [Related]
20. Different effect of 5,6-trans-prostaglandin E2 on plasminogen activation by urokinase and streptokinase.
Urano T; Ikeda C; Shimokawa M; Kinoshita T
Biochim Biophys Acta; 1994 Apr; 1205(2):258-61. PubMed ID: 8155706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
